MM
Michael R Megna
Chief Accounting Officer

Michael R Megna insider trades: Kiniksa Pharmaceuticals International (KNSA) stock sales

Chief Accounting Officer, Kiniksa Pharmaceuticals International Last trade Oct 30, 2026 42 Form 4 filings
$4.1M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 30, 2026KNSA↓ Sell$3.4M
Sep 3, 2026KNSA↓ Sell$369K
Apr 9, 2026KNSA↓ Sell$309K
Oct 20, 2025KNSA↓ Sell$2.0M
Sep 3, 2025KNSA↓ Sell$383K
Aug 4, 2025KNSA↓ Sell$550K
Jun 3, 2025KNSA↓ Sell$437K
May 7, 2025KNSA↓ Sell$471K
Mar 12, 2025KNSA↓ Sell$203K
Nov 29, 2024KNSA↓ Sell$194K
Mar 1, 2024KNSA↓ Sell$319K
Jan 2, 2024KNSA↓ Sell$320K
Dec 19, 2023KNSA↓ Sell$178K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other KNSA insiders

Open-market trades in the last 12 months

About Michael R Megna's insider trades

Michael R Megna is Chief Accounting Officer at Kiniksa Pharmaceuticals International (KNSA). Since Dec 19, 2023, Michael has reported no open-market purchases and 13 sales worth $9.1M on SEC Form 4. In the last 12 months: 3 sales ($4.1M).

Their filings also include option exercises (30 filings), grants and awards (23 filings), shares withheld for taxes (20 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KNSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.